The Spooking of Ichabod Crane

July, 1, 2020 | 4 Comments

Comments

  1. Just received:

    The Illusion of Evidence Based Medicine (Kindle). Jon Jureidini and Leemon B. McHenry.

    Immediately compelled.

  2. Patrick D Hahn Retweeted

    Baum Hedlund Law
    @baumhedlund
    ·
    Fascinating new book by Prof. of Psychiatry David Healy about how a published study touting the efficacy and safety of #Paxil in children became one of the most infamous clinical trials ever, leading to a fraud charge, a $3B fine and a Black Box Warning. https://amzn.to/3d9ncoV

    Baum Hedlund Law
    @baumhedlund
    ·

    Kim Witczak, Woody Matters – My Founder Story – When the coroner told Kim that Zoloft may have had something to do with Woody’s #suicide, she made it her mission to get to the bottom of it.

    https://www.myfounderstory.com/kim-witczak-woody-matters/

    Coincidentally, on the day of Woody’s death, the headline on the cover of the local newspaper read: “UK study finds link between antidepressants and suicide in teens.” 

  3. GSK wins legal case over withdrawal effects of paroxetine after 13 years and £9.33m in costs

    BMJ 2020; 370 doi: https://doi.org/10.1136/bmj.m2799 (Published 10 July 2020)Cite this as: BMJ 2020;370:m2799

    https://www.bmj.com/content/370/bmj.m2799

    A group action in the High Court in London by scores of claimants over withdrawal problems with the antidepressant paroxetine has ended in a victory for the manufacturer, GlaxoSmithKline (GSK), 13 years after the case was first launched.1

    A High Court trial was to start in February 2011 but the action was put on hold after legal aid was withdrawn and 369 claimants dropped their cases. In 2015 the litigation was revived when the remaining 124 claimants instructed new solicitors and found commercial funding.

    In 2016 GSK asked the court to bring the case to a permanent halt, but Mr Justice Foskett said he wanted to see how the case progressed in stages before deciding if it should be stopped or go to trial.2

    From the beginning, the claimants’ case had been that paroxetine, a selective serotonin reuptake inhibitor (SSRI) known …

    MAJOR SUCCESS FOR AG PRODUCT LITIGATION TEAM WITH INDEMNITY COSTS AWARD FOR GSK IN LONG-RUNNING SEROXAT LITIGATION

    https://www.addleshawgoddard.com/en/insights/insights-briefings/2020/litigation/indemnity-costs-award-for-gsk-long-running-seroxat/

    A copy of the judgment and alerter can be found on the attached links.

    https://www.hendersonchambers.co.uk/2020/07/03/addleshaw-goddard-and-henderson-chambers-secure-indemnity-costs-following-judgment-being-entered-for-gsk-in-the-long-running-seroxat-pharmaceutical-group-action/

Leave a Reply to tim